Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
CYTK logo

CYTK

NGS
Cytokinetics Incorporated
HealthcareBiotechnology
Watchlists:
Last updated: Tuesday 15th July 2025
38.26
-0.49 (-1.28%)
Prev Close:38.58
Open:38.73
Bid:38.2
Ask:38.27
52 Week Range
29.31
61.38
Volume:1,764,275
Mkt Cap:4,090 M
Price Target
$44.00
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

CYTK - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization10 M12 M6 M2 M2 M1 M-1 M-2 M-700000.0-600000.0
Gain On Sale Of Security1 M
General And Administrative Expense215 M174 M178 M97 M53 M40 M31 M36 M28 M20 M
Gross Profit Margin (profit Margin After CGS)-321 M8 M-146 M-90 M-41 M27 M32 M13 M106 M29 M
Interest Expense Non Operating38 M28 M51 M29 M39 M7 M4 M3 M3 M268000.0
Interest Expense Operating-2 M-94000.0
Misc Other Special Charges52 M28 M11 M331000.05 M5 M
Net Income (loss)-590 M-526 M-389 M-215 M-127 M-122 M-106 M-128 M16 M-38 M
Net Income Common Stockholders-590 M-526 M-389 M-215 M-127 M-122 M-106 M-128 M16 M-38 M
Net Income Continuous Operations-590 M-526 M-389 M-215 M-127 M-122 M-106 M-128 M16 M-38 M
Net Income From Other Gains Losses-57 M-13 M-23 M-21 M-18 M-14 M
Net Non Operating Interest Income Expense-38 M-28 M40 M-16 M-16 M-7 M394000.0-414000.0-2 M-94000.0
Non Recurring Operation Expense-4 M
Normalized Income-516 M
Operating Income-536 M-496 M-324 M-186 M-94 M-99 M-89 M-113 M19 M-37 M
Operating Income Before Depreciation (EBITDA)-575 M-502 M-332 M-184 M-87 M-96 M-85 M-109 M18 M-37 M
Operating Expense555 M504 M178 M257 M150 M126 M-120 M-127 M-88 M-66 M
Other Gand A215 M174 M178 M97 M53 M40 M31 M36 M28 M20 M
Other Impairment Of Capital Assets3 M
Other Operating Expenses-6 M-7 M-4 M-802000.0-603000.0-447000.0-110000.0-2 M-845000.0-441000.0
Rent And Landing Fees31 M36 M28 M20 M
Research Expense339 M330 M241 M160 M97 M86 M89 M90 M60 M46 M
Salaries And Wages98 M72 M-10 M-9 M-7 M-5 M
Total Income Available For Interest Expense (EBIT)-552 M-498 M-338 M-186 M-89 M-94 M-85 M-111 M17 M-37 M
Total Revenues18 M8 M95 M70 M56 M27 M32 M13 M106 M29 M
Total Expenses555 M504 M419 M257 M150 M126 M-120 M-127 M-88 M-66 M
Total Revenue18 M8 M95 M70 M56 M27 M32 M13 M106 M29 M
Amord112000.079000.066000.0
Avgshs111979.096524.089825.076886.064524.058 M54 M49 M40 M39 M
Avgshsdt111979.096524.089825.076886.064524.058 M55 M49 M43 M39 M
Basiceps-5.26-5.45-4.33-2.8-1.97-2.11-2.590.41-0.97
Basicepscont-5.26-5.45-4.33-2.8-1.97-2.11
Cor339 M330 M241 M160 M97 M
Depamor10 M12 M6 M2 M2 M1 M-1 M-2 M-700000.0-600000.0
Dileps-5.26-5.45-4.33-2.8-1.97-2.11-1.95-2.590.39-0.97
Dilepscont-5.26-5.45-4.33
Intinc11 M1000000.05 M5 M4 M3 M464000.0174000.0
Netincdisc-590 M-526 M-389 M-215 M-127 M-122 M-106 M-128 M16 M-38 M
Othincexp-53 M-28 M-25 M-331000.0-5 M-5 M-100000.0
Pretaxinc-590 M-497 M-389 M-202 M-105 M-101 M-89 M-114 M16 M-38 M
Resdev339 M330 M241 M160 M97 M86 M89 M90 M60 M46 M
Sga215 M174 M178 M97 M53 M40 M31 M36 M28 M20 M
Shsout118 M103 M95 M85 M71 M59 M55 M54 M42 M40 M
Specincchg5 M
Taxprov-1000.0-1000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader